Sun Pharma’s Anti-Cancer Drug Exempted From Price Cap
Posted by
www.biotecnika.org
Sun pharma exempted from price-control by NPPA The National
Pharmaceutical Pricing Authority has exempted Sun Pharmaceutical
Industries' anti-cancer drug gemcitabine hydrochloride injection from
price control in its last meeting. The approval for the ready-to-use
infusion bags anti-cancer gemcitabine hydrochloride injection. It
exhibits anti-tumor activity and is also used to treat various kinds
of cancer. Under […]
The post Sun Pharma's Anti-Cancer Drug Exempted From Price Cap
appeared first on Rasayanika .
https://www.rasayanika.com/2019/11/14/sun-pharma-exempted-from-price-control-by-nppa/
News
Subscribe to:
Post Comments (Atom)
Post a Comment